MAP'ing CNS Development and Cognition: An ERKsome Process

Neuron

Volumn 61, Issue 2, 2009, Pages 160-167

  Samuels, Ivy S ^a,b,c   Saitta, Sulagna C ^d   Landreth, Gary E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROFIBROMIN; PROTEIN TYROSINE PHOSPHATASE SHP 2;

AUTISM; BRAIN; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHROMOSOME 22Q; CHROMOSOME DELETION; COFFIN LOWRY SYNDROME; COGNITION; COGNITIVE DEFECT; COSTELLO SYNDROME; DIGEORGE SYNDROME; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LEARNING; LEOPARD SYNDROME; MEMORY; NEURAL CREST; NEUROFIBROMATOSIS; NONHUMAN; NOOMAN SYNDROME; PRIORITY JOURNAL; SHORT SURVEY; X LINKED MENTAL RETARDATION;

ANIMALS; BRAIN; CHILD, PRESCHOOL; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAP KINASE SIGNALING SYSTEM; NERVOUS SYSTEM MALFORMATIONS; SYNDROME;

EID: 58549105755     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.01.001     Document Type: Short Survey

References (77)

1. Antshel K.M., Kates W.R., Roizen N., Fremont W., and Shprintzen R.J. 22q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features keywords. Child Neuropsychol. 11 (2005) 5-19
2. Aoki Y., Niihori T., Narumi Y., Kure S., and Matsubara Y. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum. Mutat. 29 (2008) 992-1006
3. Aouadi M., Binetruy B., Caron L., Le Marchand-Brustel Y., and Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88 (2006) 1091-1098
4. Ballif B.C., Hornor S.A., Jenkins E., Madan-Khetarpal S., Surti U., Jackson K.E., Asamoah A., Brock P.L., Gowans G.C., Conway R.L., et al. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat. Genet. 39 (2007) 1071-1073
5. Ben-Shachar S., Ou Z., Shaw C.A., Belmont J.W., Patel M.S., Hummel M., Amato S., Tartaglia N., Berg J., Sutton V.R., et al. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am. J. Hum. Genet. 82 (2008) 214-221
6. Bentires-Alj M., Kontaridis M.I., and Neel B.G. Stops along the RAS pathway in human genetic disease. Nat. Med. 12 (2006) 283-285
7. Brems H., Chmara M., Sahbatou M., Denayer E., Taniguchi K., Kato R., Somers R., Messiaen L., De Schepper S., Fryns J.P., et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat. Genet. 39 (2007) 1120-1126
8. Chi C.L., Martinez S., Wurst W., and Martin G.R. The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum. Development 130 (2003) 2633-2644
9. Christen B., and Slack J.M. Spatial response to fibroblast growth factor signalling in Xenopus embryos. Development 126 (1999) 119-125
10. Corson L.B., Yamanaka Y., Lai K.M., and Rossant J. Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development 130 (2003) 4527-4537
11. Cui Y., Costa R.M., Murphy G.G., Elgersma Y., Zhu Y., Gutmann D.H., Parada L.F., Mody I., and Silva A.J. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135 (2008) 549-560
12. Davis S., and Laroche S. Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review. Genes Brain Behav. 5 Suppl 2 (2006) 61-72
13. Debbane M., Schaer M., Farhoumand R., Glaser B., and Eliez S. Hippocampal volume reduction in 22q11.2 deletion syndrome. Neuropsychologia 44 (2006) 2360-2365
14. Deboer T., Wu Z., Lee A., and Simon T.J. Hippocampal volume reduction in children with chromosome 22q11.2 deletion syndrome is associated with cognitive impairment. Behav. Brain Funct. 3 (2007) 54
15. Delrue M.A., Chateil J.F., Arveiler B., and Lacombe D. Costello syndrome and neurological abnormalities. Am. J. Med. Genet. A. 123 (2003) 301-305
16. Denayer E., de Ravel T., and Legius E. Clinical and Molecular Aspects of RAS-related disorders. J. Med. Genet. 45 (2008) 695-703
17. Descheemaeker M.J., Roelandts K., De Raedt T., Brems H., Fryns J.P., and Legius E. Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am. J. Med. Genet. A. 131 (2004) 325-326
18. Eckel-Mahan K.L., Phan T., Han S., Wang H., Chan G.C., Scheiner Z.S., and Storm D.R. Circadian oscillation of hippocampal MAPK activity and cAMP: implications for memory persistence. Nat. Neurosci., in press. Published online August 10, 2008. (2008) 10.1038/nn.2174
19. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., Landreth G.E., Manji H.K., and Chen G. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry (2008) 10.1038/sj.mp.4002135 in press. Published online January 29, 2008
20. English J.D., and Sweatt J.D. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J. Biol. Chem. 271 (1996) 24329-24332
21. Ferguson S.M., Fasano S., Yang P., Brambilla R., and Robinson T.E. Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 31 (2006) 2660-2668
22. Ferner R.E. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 6 (2007) 340-351
23. Frank D.U., Fotheringham L.K., Brewer J.A., Muglia L.J., Tristani-Firouzi M., Capecchi M.R., and Moon A.M. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129 (2002) 4591-4603
24. Galabova-Kovacs G., Catalanotti F., Matzen D., Reyes G.X., Zezula J., Herbst R., Silva A., Walter I., and Baccarini M. Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development. J. Cell Biol. 180 (2008) 947-955
25. Gauthier A.S., Furstoss O., Araki T., Chan R., Neel B.G., Kaplan D.R., and Miller F.D. Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron 54 (2007) 245-262
26. Gelb B.D., and Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 15 Suppl 2 (2006) R220-R226
27. Ghebranious N., Giampietro P.F., Wesbrook F.P., and Rezkalla S.H. A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. Am. J. Med. Genet. A. 143 (2007) 1462-1471
28. Grueter B.A., Gosnell H.B., Olsen C.M., Schramm-Sapyta N.L., Nekrasova T., Landreth G.E., and Winder D.G. Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J. Neurosci. 26 (2006) 3210-3219
29. Guris D.L., Duester G., Papaioannou V.E., and Imamoto A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell 10 (2006) 81-92
30. Hadari Y.R., Gotoh N., Kouhara H., Lax I., and Schlessinger J. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. USA 98 (2001) 8578-8583
31. Harvey C.D., Yasuda R., Zhong H., and Svoboda K. The spread of Ras activity triggered by activation of a single dendritic spine. Science 321 (2008) 136-140
32. Hegedus B., Dasgupta B., Shin J.E., Emnett R.J., Hart-Mahon E.K., Elghazi L., Bernal-Mizrachi E., and Gutmann D.H. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell 1 (2007) 443-457
33. Inglis-Broadgate S.L., Thomson R.E., Pellicano F., Tartaglia M.A., Pontikis C.C., Cooper J.D., and Iwata T. FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development. Dev. Biol. 279 (2005) 73-85
34. Kawauchi S., Shou J., Santos R., Hebert J.M., McConnell S.K., Mason I., and Calof A.L. Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse. Development 132 (2005) 5211-5223
35. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., Gilliam T.C., Nowak N.J., Cook Jr. E.H., Dobyns W.B., and Christian S.L. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17 (2008) 628-638
36. Lee D.A., Portnoy S., Hill P., Gillberg C., and Patton M.A. Psychological profile of children with Noonan syndrome. Dev. Med. Child Neurol. 47 (2005) 35-38
37. Leppig K.A., Kaplan P., Viskochil D., Weaver M., Ortenberg J., and Stephens K. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am. J. Med. Genet. 73 (1997) 197-204
38. Lindsay E.A. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2 (2001) 858-868
39. Lunn J.S., Fishwick K.J., Halley P.A., and Storey K.G. A spatial and temporal map of FGF/Erk1/2 activity and response repertoires in the early chick embryo. Dev. Biol. 302 (2007) 536-552
40. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., Wolfer D.P., Pages G., Valverde O., et al. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34 (2002) 807-820
41. Menard C., Hein P., Paquin A., Savelson A., Yang X.M., Lederfein D., Barnabe-Heider F., Mir A.A., Sterneck E., Peterson A.C., et al. An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36 (2002) 597-610
42. Meyers E.N., Lewandoski M., and Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18 (1998) 136-141
43. Moon A.M., Guris D.L., Seo J.H., Li L., Hammond J., Talbot A., and Imamoto A. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell 10 (2006) 71-80
44. Newbern J., Zhong J., Wickramasinghe S., Li X., Wu Y., Samuels I., Cherosky N., Karlo J., O'Loughlin B., Wikenheiser J., et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc. Natl. Acad. Sci. USA (2008) in press
45. Pandit B., Sarkozy A., Pennacchio L.A., Carta C., Oishi K., Martinelli S., Pogna E.A., Schackwitz W., Ustaszewska A., Landstrom A., et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 39 (2007) 1007-1012
46. Paquin A., Barnabe-Heider F., Kageyama R., and Miller F.D. CCAAT/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo. J. Neurosci. 25 (2005) 10747-10758
47. Pontious A., Kowalczyk T., Englund C., and Hevner R.F. Role of intermediate progenitor cells in cerebral cortex development. Dev. Neurosci. 30 (2008) 24-32
48. Rauch A., Pfeiffer R.A., Leipold G., Singer H., Tigges M., and Hofbeck M. A novel 22q11.2 microdeletion in DiGeorge syndrome. Am. J. Hum. Genet. 64 (1999) 659-666
49. Rauen K.A. HRAS and the Costello syndrome. Clin. Genet. 71 (2007) 101-108
50. Razzaque M.A., Nishizawa T., Komoike Y., Yagi H., Furutani M., Amo R., Kamisago M., Momma K., Katayama H., Nakagawa M., et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat. Genet. 39 (2007) 1013-1017
51. Roberts A., Allanson J., Jadico S.K., Kavamura M.I., Noonan J., Opitz J.M., Young T., and Neri G. The cardiofaciocutaneous syndrome. J. Med. Genet. 43 (2006) 833-842
52. Rubinfeld H., and Seger R. The ERK cascade: a prototype of MAPK signaling. Mol. Biotechnol. 31 (2005) 151-174
53. Saitta S.C., McGrath J.M., Mensch H., Shaikh T.H., Zackai E.H., and Emanuel B.S. A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects. Am. J. Hum. Genet. 65 (1999) 562-566
54. Samuels I.S., Karlo J.C., Faruzzi A.N., Pickering K., Herrup K., Sweatt J.D., Saitta S.C., and Landreth G.E. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J. Neurosci. 28 (2008) 6983-6995
55. Satoh Y., Endo S., Ikeda T., Yamada K., Ito M., Kuroki M., Hiramoto T., Imamura O., Kobayashi Y., Watanabe Y., et al. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J. Neurosci. 27 (2007) 10765-10776
56. Scambler P.J. The 22q11 deletion syndromes. Hum. Mol. Genet. 9 (2000) 2421-2426
57. Schaer M., Schmitt J.E., Glaser B., Lazeyras F., Delavelle J., and Eliez S. Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res. 146 (2006) 1-11
58. Selcher J.C., Nekrasova T., Paylor R., Landreth G.E., and Sweatt J.D. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn. Mem. 8 (2001) 11-19
59. Shaikh T.H., O'Connor R.J., Pierpont M.E., McGrath J., Hacker A.M., Nimmakayalu M., Geiger E., Emanuel B.S., and Saitta S.C. Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res. 17 (2007) 482-491
60. Shalin S.C., Egli R., Birnbaum S.G., Roth T.L., Levenson J.M., and Sweatt J.D. Signal transduction mechanisms in memory disorders. Prog. Brain Res. 157 (2006) 25-41
61. Shin D.M., Korada S., Raballo R., Shashikant C.S., Simeone A., Taylor J.R., and Vaccarino F. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J. Neurosci. 24 (2004) 2247-2258
62. Shinya M., Koshida S., Sawada A., Kuroiwa A., and Takeda H. Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos. Development 128 (2001) 4153-4164
63. Simon T.J., Wu Z., Avants B., Zhang H., Gee J.C., and Stebbins G.T. Atypical cortical connectivity and visuospatial cognitive impairments are related in children with chromosome 22q11.2 deletion syndrome. Behav. Brain Funct. 4 (2008) 25
64. Storm E.E., Garel S., Borello U., Hebert J.M., Martinez S., McConnell S.K., Martin G.R., and Rubenstein J.L. Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers. Development 133 (2006) 1831-1844
65. Tartaglia M., Kalidas K., Shaw A., Song X., Musat D.L., van der Burgt I., Brunner H.G., Bertola D.R., Crosby A., Ion A., et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70 (2002) 1555-1563
66. Thomas G.M., and Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5 (2004) 173-183
67. Thomson R.E., Pellicano F., and Iwata T. Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen-activated protein kinase activation. J. Neurochem. 100 (2007) 1565-1578
68. Vaccarino F.M., Schwartz M.L., Raballo R., Nilsen J., Rhee J., Zhou M., Doetschman T., Coffin J.D., Wyland J.J., and Hung Y.T. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat. Neurosci. 2 (1999) 246-253
69. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008) 667-675
70. Wurdak H., Ittner L.M., and Sommer L. DiGeorge syndrome and pharyngeal apparatus development. Bioessays 28 (2006) 1078-1086
71. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
72. Yamamoto S., Yoshino I., Shimazaki T., Murohashi M., Hevner R.F., Lax I., Okano H., Shibuya M., Schlessinger J., and Gotoh N. Essential role of Shp2-binding sites on FRS2alpha for corticogenesis and for FGF2-dependent proliferation of neural progenitor cells. Proc. Natl. Acad. Sci. USA 102 (2005) 15983-15988
73. Yasuda T., Sanjo H., Pages G., Kawano Y., Karasuyama H., Pouyssegur J., Ogata M., and Kurosaki T. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28 (2008) 499-508
74. Yntema H.G., van den Helm B., Kissing J., van Duijnhoven G., Poppelaars F., Chelly J., Moraine C., Fryns J.P., Hamel B.C., Heilbronner H., et al. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62 (1999) 332-343
75. Yoshida R., Hasegawa T., Hasegawa Y., Nagai T., Kinoshita E., Tanaka Y., Kanegane H., Ohyama K., Onishi T., Hanew K., et al. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome. J. Clin. Endocrinol. Metab. 89 (2004) 3359-3364
76. Zheng W., Nowakowski R.S., and Vaccarino F.M. Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone. Dev. Neurosci. 26 (2004) 181-196
77. Zhong J., Li X., McNamee C., Chen A.P., Baccarini M., and Snider W.D. Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo. Nat. Neurosci. 10 (2007) 598-607